Some studies indicated that cytological specimens were suitable for EGFR and KRAS testing in patients with NSCLC using different specimens, such as cell block, liquid-based cytology (LBC) or conventional smears and fresh tumor cells [3–9]. Here, EGFR is linked to neoplasm.